The California Institute for Regenerative Medicine Science, Governance, and the Pursuit of Cures (2013) / Chapter Skim
Currently Skimming:
Appendix C: Proposition 71
Appendix C: Proposition 71
Pages 159-176
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 159... ...
Appendix C Proposition 71 159
|
From page 160... ...
This initiative measure is submitted to the people in accordance with the provisions of Section 8 of The California Stem Cell Research and Cures Article II of the California Constitution. Act will close this funding gap by establishing an institute which will issue bonds to support stem cell This initiative measure expressly amends the research, emphasizing pluripotent stem cell and California Constitution by adding an article thereto; progenitor cell research and other vital medical and amends a section of the Government Code, and technologies, for the development of life-saving adds sections to the Health and Safety Code; regenerative medical treatments and cures.
|
From page 161... ...
The Chancellors of the University of conduct stem cell research which includes research California at San Francisco, Davis, San Diego, Los involving adult stem cells, cord blood stem cells, Angeles, and Irvine, shall each appoint an executive pluripotent stem cells, and/or progenitor stem cells. officer from his or her campus.
|
From page 162... ...
The President pro Tempore of the Senate research institution that is not a part of the shall appoint a member from among California University of California, that has demonstrated representatives of a California regional, state, or success and leadership in stem cell research, and that national HIV/AIDS disease advocacy group.
|
From page 163... ...
. The vice administrative expenses; an assessment of the chairperson shall be selected from among individuals availability of funding for stem cell research from who have attributes and experience complementary sources other than the institute; a summary of to those of the chairperson, preferably covering the research findings, including promising new research criteria not represented by the chairperson's areas; an assessment of the relationship between the credentials and experience.
|
From page 164... ...
compound, procedure, production data, or compilation of information, which is not patented, (3) The ICOC may conduct closed sessions as which is known only to certain individuals who are permitted by the Bagley-Keene Open Meeting Act, using it to fabricate, produce, or compound an article under Section 11126 of the Government Code.
|
From page 165... ...
Service as a member of the ICOC by a future state laws or regulations dealing with the representative or employee of a disease advocacy study and research of pluripotent stem cells and/or organization, a nonprofit academic and research progenitor cells, or other vital research institution, or a life science commercial entity shall opportunities, except Section 125315. The ICOC, its not be deemed to be inconsistent, incompatible, in working committees, and its grantees shall be conflict with, or inimical to the duties of the ICOC governed solely by the provisions of this act in the member as a representative or employee of that establishment of standards, the award of grants, and organization, institution, or entity.
|
From page 166... ...
implantation or legal transaction or other (l) Request the issuance of bonds from the administrative costs associated with these medical California Stem Cell Research and Cures Finance procedures and specifically including any required Committee and loans from the Pooled Money payments for medical or scientific technologies, Investment Board.
|
From page 167... ...
Notwithstanding Section 19825 of the (A) The chairperson's primary responsibilities Government Code, the ICOC shall set compensation are to manage the ICOC agenda and work flow for the chairperson, vice chairperson, and president including all evaluations and approvals of scientific and other officers, and for the scientific, medical, and medical working group grants, loans, facilities, technical, and administrative staff of the institute and standards evaluations, and to supervise all within the range of compensation levels for executive annual reports and public accountability officers and scientific, medical, technical, and requirements; to manage and optimize the institute's administrative staff of medical schools within the bond financing plans and funding cash flow plan; to University of California system and the nonprofit interface with the California Legislature, the United academic and research institutions described in States Congress, the California health care system, paragraph (2)
|
From page 168... ...
Fifteen scientists nationally recognized in the field of stem cell research.
|
From page 169... ...
In order to ensure that institute funding does (1) Recommend to the ICOC interim and final not duplicate or supplant existing funding, a high criteria, standards, and requirements for considering priority shall be placed on funding pluripotent stem funding applications and for awarding research cell and progenitor cell research that cannot, or is grants and loans.
|
From page 170... ...
Moneys in the California Stem Cell Research achieving such milestones. and Cures Fund shall be allocated as follows: (B)
|
From page 171... ...
125291.10. This article shall be known, and may In addition, moneys in the fund or other proceeds of be cited, as the California Stem Cell Research and the sale of bonds authorized by this article may be Cures Bond Act of 2004.
|
From page 172... ...
Upon such initial determination, State General Obligation Bond Law, of the bonds and the committee may delegate, by resolution, to the interim debt authorized by this article, the California Treasurer such authority in connection with issuance Stem Cell Research and Cures Finance Committee is of bonds as it may determine, including, but not hereby created. For purposes of this article, the limited to, the authority to implement and continue California Stem Cell Research and Cures Finance this bond financing structure (including during any Committee is "the committee" as that term is used in time following the initial five-year period)
|
From page 173... ...
As used in this chapter and in Article Money Investment Board to make a loan from the XXXV of the California Constitution, the following Pooled Money Investment Account in accordance terms have the following meanings: with Section 16312 of the Government Code for the (a) "Act" means the California Stem Cell purposes of carrying out this article.
|
From page 174... ...
"Vital research opportunity" means scientific capable of self-renewal, and have broad potential to and medical research and technologies and/or any differentiate into multiple adult cell types. Pluripotent stem cell research not actually funded by the institute stem cells may be derived from somatic cell nuclear under subparagraph (C)
|
From page 175... ...
"State service" means service rendered as an employee or officer (employed, appointed or elected) of the state, the California Institute for Regenerative Medicine and the officers and employees of its governing body, the university, a school employer, or a contracting agency, for compensation, and only while he or she is receiving compensation from that employer therefor, except as provided in Article 4 (commencing with Section 20990)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.